Söreskog, E.
Lopez, B.
Bean, T.
Lewis, P.
Ashley, N.
Da Palma Lopes, J.
Meertens, R.
Ratcliffe, A.
Article History
Received: 14 July 2024
Accepted: 17 December 2024
First Online: 4 February 2025
Declarations
:
: Not applicable.
: Not applicable.
: BL and AR from IBEX Innovations hold the intellectual property rights over the IBEX BH technology and have a vested interest in the adoption of this technology into clinical practice. ES is employed by Macanda which was funded by IBEX Innovations to conduct this study.